Lv21
190 积分 2023-04-22 加入
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
4小时前
待确认
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
4小时前
已完结
A case of psoriasis with IgA nephropathy successfully treated with secukinumab
28天前
已完结
Psoriasis‐associated IgA nephropathy under infliximab therapy
28天前
已完结
Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients with STable CoROnary Artery Disease CoMpared to Placebo (EKSTROM) Trial – Rationale and Design
1个月前
已完结
Inhibitors of apolipoprotein C3, triglyceride levels, and risk of pancreatitis: a systematic review and meta-analysis
2个月前
已完结
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
3个月前
已完结
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3
3个月前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
4个月前
已完结
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
4个月前
已完结
皖公网安备34019202002308
